509 related articles for article (PubMed ID: 26419725)
1. The complexity of epigenetic diseases.
Brazel AJ; Vernimmen D
J Pathol; 2016 Jan; 238(2):333-44. PubMed ID: 26419725
[TBL] [Abstract][Full Text] [Related]
2. [Colorectal cancer is typified by enhancer specific epigenetic mutations].
Brunelle M; Gévry N; Lupien M
Med Sci (Paris); 2012 Nov; 28(11):929-31. PubMed ID: 23171894
[No Abstract] [Full Text] [Related]
3. Immune disease-associated variants in gene enhancers point to BET epigenetic mechanisms for therapeutic intervention.
Tough DF; Prinjha RK
Epigenomics; 2017 Apr; 9(4):573-584. PubMed ID: 27925476
[TBL] [Abstract][Full Text] [Related]
4. Can genome engineering be used to target cancer-associated enhancers?
Grimmer MR; Farnham PJ
Epigenomics; 2014; 6(5):493-501. PubMed ID: 25431942
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic epidemiology for cancer risk: harnessing germline epigenetic variation.
Brennan K; Flanagan JM
Methods Mol Biol; 2012; 863():439-65. PubMed ID: 22359310
[TBL] [Abstract][Full Text] [Related]
6. Disease-Associated Single-Nucleotide Polymorphisms From Noncoding Regions in Juvenile Idiopathic Arthritis Are Located Within or Adjacent to Functional Genomic Elements of Human Neutrophils and CD4+ T Cells.
Jiang K; Zhu L; Buck MJ; Chen Y; Carrier B; Liu T; Jarvis JN
Arthritis Rheumatol; 2015 Jul; 67(7):1966-77. PubMed ID: 25833190
[TBL] [Abstract][Full Text] [Related]
7. Using epigenome-wide association scans of DNA methylation in age-related complex human traits.
Tsai PC; Spector TD; Bell JT
Epigenomics; 2012 Oct; 4(5):511-26. PubMed ID: 23130833
[TBL] [Abstract][Full Text] [Related]
8. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
[TBL] [Abstract][Full Text] [Related]
9. The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseases.
Ahsan M; Ek WE; Rask-Andersen M; Karlsson T; Lind-Thomsen A; Enroth S; Gyllensten U; Johansson Å
PLoS Genet; 2017 Sep; 13(9):e1007005. PubMed ID: 28915241
[TBL] [Abstract][Full Text] [Related]
10. Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.
Cohen AJ; Saiakhova A; Corradin O; Luppino JM; Lovrenert K; Bartels CF; Morrow JJ; Mack SC; Dhillon G; Beard L; Myeroff L; Kalady MF; Willis J; Bradner JE; Keri RA; Berger NA; Pruett-Miller SM; Markowitz SD; Scacheri PC
Nat Commun; 2017 Feb; 8():14400. PubMed ID: 28169291
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association studies and epigenome-wide association studies go together in cancer control.
Verma M
Future Oncol; 2016 Jul; 12(13):1645-64. PubMed ID: 27079684
[TBL] [Abstract][Full Text] [Related]
12. [Epigenetics--cellular memories--affect disease development].
Ohlsson R; Göndor A
Lakartidningen; 2006 Mar 22-28; 103(12):919-25. PubMed ID: 16618035
[No Abstract] [Full Text] [Related]
13. The cancer epigenome--components and functional correlates.
Ting AH; McGarvey KM; Baylin SB
Genes Dev; 2006 Dec; 20(23):3215-31. PubMed ID: 17158741
[TBL] [Abstract][Full Text] [Related]
14. MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.
Tong Y; Sun J; Wong CF; Kang Q; Ru B; Wong CN; Chan AS; Leung SY; Zhang J
Genome Biol; 2018 Jun; 19(1):73. PubMed ID: 29871649
[TBL] [Abstract][Full Text] [Related]
15. Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.
Brien GL; Valerio DG; Armstrong SA
Cancer Cell; 2016 Apr; 29(4):464-476. PubMed ID: 27070701
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic epidemiology: is there cause for optimism?
Ramsay M
Epigenomics; 2015 Aug; 7(5):683-5. PubMed ID: 26317443
[No Abstract] [Full Text] [Related]
17. Enhancer Dysfunction in 3D Genome and Disease.
Xia JH; Wei GH
Cells; 2019 Oct; 8(10):. PubMed ID: 31635067
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inflammation in diabetes: From genetics to epigenomics evidence.
Diedisheim M; Carcarino E; Vandiedonck C; Roussel R; Gautier JF; Venteclef N
Mol Metab; 2020 Nov; 41():101041. PubMed ID: 32603690
[TBL] [Abstract][Full Text] [Related]
19. Cancer induction and suppression with transcriptional control and epigenome editing technologies.
Nakade S; Yamamoto T; Sakuma T
J Hum Genet; 2018 Feb; 63(2):187-194. PubMed ID: 29215091
[TBL] [Abstract][Full Text] [Related]
20. Genetic and epigenetic fine mapping of causal autoimmune disease variants.
Farh KK; Marson A; Zhu J; Kleinewietfeld M; Housley WJ; Beik S; Shoresh N; Whitton H; Ryan RJ; Shishkin AA; Hatan M; Carrasco-Alfonso MJ; Mayer D; Luckey CJ; Patsopoulos NA; De Jager PL; Kuchroo VK; Epstein CB; Daly MJ; Hafler DA; Bernstein BE
Nature; 2015 Feb; 518(7539):337-43. PubMed ID: 25363779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
